2 years ago

Private Information Regarding MK-1775 Made Known

On the 40 individuals, all 10 who obtained sofosbuvir plus RBV devoid of IFN and all thirty who obtained sofosbuvir plus RBV for 12 weeks and IFN for four, 8, or twelve weeks had an SVR at 24 weeks. The presence or absence of pegIFN alfa-2a appear read more...

2 years ago

Confidential Information Regarding ML347 Made Known

They obtained dual oral treatment for 24 weeks with daclatasvir and asunaprevir. The primary efficacy end stage was SVR12. General, 76.7% of patients attained SVR12